Driving the Deal Podcast | Analyzing Shifts in Healthcare Private Equity Trends
Apr 2021
Barry Freeman, Managing Director and Co-head of Healthcare at Lincoln International joins McDermott Partner Krist Werling in a recent episode of the Collaborative Transformation: Driving the Deal series to speak about current trends and topics surrounding the evolution of healthcare and its impact on private equity. They discuss:
- A shifting mindset surrounding deals in the payor market
- Key questions private equity investors want answered before investing in healthcare
- Growth trends in government payor plans and their impact on providers
- Investor insights into the home healthcare and telehealth spaces
Summary
-
In April 2021, Barry Freeman, Managing Director and Co-head of Healthcare at Lincoln International was featured on the McDermott Health Podcast to speak about current trends and topics surrounding the evolution of healthcare and its impact on private equity.
- Sign up to receive Lincoln's perspectives
Contributor
Meet Professionals with Complementary Expertise in Healthcare
I enjoy working closely with clients to overcome challenging situations and to develop strategies to meet their business goals.
Dirk-Oliver Löffler
Managing Director | European Co-head Healthcare
Frankfurt
Related Perspectives in Healthcare
PETS International | Consolidation Meets Regulation in the Veterinary Clinics Market
Originally posted by PETS International on April 5, 2024. Animal health is becoming a big business in Europe and the U.S. Thus, regulators are turning a closer eye to mergers… Read More
“Leader to Leader” Series
The Leader to Leader video series turns up the dial on rich conversations with prominent leaders – from business owners and entrepreneurs to investors and CEOs – highlighting their stories… Read More
What Price is Right? Trends and Opportunities for Private Equity in Pharma Market Access
The cost of developing new drugs is staggering. Among the top 20 global biopharmas, the average cost of developing a candidate from discovery through clinical trials to market was approximately… Read More
Investment Opportunities in Pharma: A Data-Driven Exploration of CDMO Appeal
The report discusses the current state of the contract development and manufacturing organization (CDMO) market within the pharmaceutical industry, emphasizing the increased interest from private equity (PE) investors. The pharmaceutical… Read More
